Indy Hematology Review
Avatar

Improvements in Treating Ph-like ALL, Trials in Pre B-ALL & Blinatumomab for MRD-Positive ALL

By Indy Hematology Review FEATURING Hagop Kantarjian
By Indy Hematology Review FEATURING Hagop Kantarjian
0 views
August 19, 2019
Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

01:29
Incyte

Targeting CSF-1R to Manage Inflammation and Fibrosis in GVHD

Recommended

AUTOPLAY
08:18
Insights from 2023 ASH Annual Meeting

Treatment Strategies for Hematocrit Control in PV

Feat. A. Zhou
09:51
i3 Health

MRD Testing in Leukemias: When Negativity Is a Positive Thing

Feat. N. S. Raje
06:00
2024 Clinical Case Studies

Clinical Case Review: A Not-So-Sweet Case of Vulvar Ulceration

Feat. A. Geisler
14:39
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

Immunotherapies in Acute Leukemias: 2024 Update

Feat. C. Lai
23:15
Rush University Medical Center

Is Post-HSCT Maintenance the SOC for AML?

Feat. M. Levis
16:28
Fred Hutchinson Cancer Center

Blinatumomab for Ph- ALL in First MRD-Negative Remission: E1910 and …

Feat. R. Cassaday
15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay
09:27
ASH 2022 Conference Coverage

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

Feat. M. McMullin
04:02
Michael Burke

Updated Results from the BLAST and TOWER Studies: Safety and Efficac…

16:25
Northwestern Medicine Oncology and Hematology

Diagnosis and Goals of Therapy in PV

Feat. B. Stein
28:07
Indy Hematology Review

Controversies and Recommendations for the Treatment of ALL and Lymph…

Feat. W. Stock
06:51
Insights from 2023 ASH Annual Meeting

Prevalence and Prediction of Ruxolitinib Treatment Emergent Thromboc…

Feat. D. Tremblay
11:35
Vanderbilt University Medical Center (VUMC)

Prevention and Management of Post-SCT Relapse in Acute Leukemias

Feat. A. Jallouk
31:00
Louisville Hematology Highlights

Current Approaches in the Frontline Treatment of Adult ALL

Feat. N. Short
10:49
Monia Marchetti

Using Cytoreductive Therapy to Prevent Cardiovascular Events in Pati…

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter
18:19
Yale Cancer Center

Summary of Recent Advances in Adult ALL

Feat. L. Mendez
48:05
Yale Cancer Center

ALL - Progress in Research and Therapy in 2022

Feat. H. Kantarjian
18:39
Fred Hutchinson Cancer Center

MRD Positivity in ALL: Next Steps in Clinical Approach

Feat. R. Cassaday
08:22
SOHO 2023 Eleventh Annual Meeting

SOHO 2023 First Report of Phase 3 PhALLCON Study: Comparing Ponatini…

Feat. E. Jabbour